By the numbers: Antidepressants on the riseThe number of prescriptions for antidepressants rose during the COVID-19 pandemic, and patients need to know what’s needed to stop if their symptoms have improved. New guidelines on type 2 diabetes remissionRemission is not synonymous with cure. Rather, the term remission reflects the often-temporary resolution of hyperglycemia, and subsequent possible relapse with progression of type 2 diabetes. A pharmacist’s guide to managing bipolar disorder Bipolar disorder is a chronic condition that requires life-long therapy in most patients in order to prevent relapses. Drug access shortfall Health equity for Canadians is elusive with current prescription patchwork. Pharmacy pet peeves Doctors share what they find frustrating about pharmacists—and pharmacists respond. More IMGs—faster How Canada can use international medical graduates generally – and Canadian IMGs – to help resolve the doctor shortage. Statins for the primary prevention of cardiovascular disease The 2021 CCS dyslipidemia guidelines recommend statin therapy for certain higher-risk primary prevention patients. Drug news—May/June 2023 A review of new launches, new indications, new dosage forms and Health Canada advisories. How to be strategic about staff retention Building a strong organizational culture and an engaged workforce is a huge part of running a practice, and one that needs relentless commitment. Five tips: Supporting a co-worker suffering from depression If you are concerned that someone you know is suffering from a mental illness, don’t be afraid to talk about it and reach out. It’s OK if this feels awkward; we aren’t used to talking openly about this subject. First Previous 21 22 23 24 25 Next Last
